Carregant...

Identification of cisplatin-binding sites on the large cytoplasmic loop of the Na(+)/K(+)-ATPase

Cisplatin is the most widely used chemotherapeutic drug for the treatment of various types of cancer; however, its administration brings also numerous side effects. It was demonstrated that cisplatin can inhibit the Na(+)/K(+)-ATPase (NKA), which can explain a large part of the adverse effects. In t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Enzyme Inhib Med Chem
Autors principals: Šeflová, Jaroslava, Čechová, Petra, Štenclová, Tereza, Šebela, Marek, Kubala, Martin
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6009960/
https://ncbi.nlm.nih.gov/pubmed/29577756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2018.1445735
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!